Regenerative medicine is an evolving interdisciplinary field of medicine focused on the repair, replacement or regeneration of cells, tissues or organs to restore impaired function resulting from any cause, including disease, trauma, congenital defects and aging. This field holds the promise of using the body’s natural healing process to regenerate damaged tissues and organs, previously irreparable. Regenerative medicine also allows scientists to use stem cells and nanotechnology to grow tissues and organs in the lab in vitro and implant them into the body.
As the demand for patients requiring organ transplantation is greater than the organs available for donation, regenerative medicine has the potential to solve the problem of organ shortage and save lives. Since the organ’s cells will match those of the patient, organ rejection is not a problem with regenerative medicine. The aim of regenerative medicine is to one day be capable of supporting the body in such a way that there will be no need for organ replacement.
Advances in stem cell science and tissue-engineered scaffolds enable regenerative medicine to be used to repair damaged tissue or organs damaged by aging and disease. Many scientists believe that stem cell treatments have the potential to alleviate suffering and change the face of human disease.
As the demand for patients requiring organ transplantation is greater than the organs available for donation, regenerative medicine has the potential to solve the problem of organ shortage and save lives. Since the organ’s cells will match those of the patient, organ rejection is not a problem with regenerative medicine. The aim of regenerative medicine is to one day be capable of supporting the body in such a way that there will be no need for organ replacement.
Advances in stem cell science and tissue-engineered scaffolds enable regenerative medicine to be used to repair damaged tissue or organs damaged by aging and disease. Many scientists believe that stem cell treatments have the potential to alleviate suffering and change the face of human disease.
All reports in Regenerative Medicine
|
Global Regenerative Medicine Market
12/1/2011 | published by: RNCOS
... laboratory-grown or therapeutically-induced human tissue as a replacement. After decades of research, many regenerative medicine technologies are in development and approaching commercialization stage, thus leading to the creation of a revenue generating industry. The market, ...
|
more...
|
$1,200.00
|
|
Translational Regenerative Medicine: Market Prospects 2011-2021
7/27/2011 | published by: Visiongain
... therapy. Through our research and analysis we aim to save you time and help in your decisions. What technologies and applications will expand that market? What will stimulate and limit regenerative medicine? See potential revenues ...
|
more...
|
$2,331.00
|
|
McGowan Institute for Regenerative Medicine - Product Pipeline Analysis
3/23/2011 | published by: GlobalData
... detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date. Each pipeline product is profiled to cover information ...
|
more...
|
$750.00
|
|
Future Directions in Regenerative Medicine
2/24/2011 | published by: Business Insights
... preclinical or Phase I study. Many also have later stage or launched products, which are covered briefly to illustrate the potential of the next generation of candidates. Scope of this research Understand the concepts behind ...
|
more...
|
$3,835.00
|
|
Regenerative Medicine
10/1/2010 | published by: Global Industry Analysts
... A six-year historic analysis is also provided for these markets. The report profiles 106 companies including many key and niche players such as BioVest International, Inc., Curis, Inc., Cytori Therapeutics, Inc., DeveloGen AG, Forticell Bioscience, ...
|
more...
|
$4,500.00
|
|
Regenerative Medicine Markets
9/1/2010 | published by: TriMark Publications
... human tissue and organ functions are being made. Whereas before, remedies for damaged tissue or organ functions due to congenital deformities, injuries, diseases or simple wear-and-tear relied upon either the body's ability to repair itself ...
|
more...
|
$3,400.00
|
|
Stem Cells Market Trends 2010: Drug Discovery/Toxicity Screening and Regenerative Medicine
4/1/2010 | published by: Select Biosciences Limited
... industry participants active in the stem cells field. This bottom-up analysis highlights market trends operative and enables the identification of trends vis-a-vis the research marketplace, utilization of different classes of stem cells, as well as ...
|
more...
|
$1,618.00
|
|
Autologous Tissue Repair
12/15/2009 | published by: Greystone Research Associates
... on a number of areas, including cardiovascular medicine, refractory wound care, orthopedics, and surgical medicine. The potential economic benefits of autologous tissue repair are significant, as an aging population struggles with intractable ailments that historically ...
|
more...
|
$2,850.00
|
|
Regenerative Medicines: Bone and Joint Applications
10/1/2009 | published by: BCC Research
... annual growth rate (CAGR) of 8.6%. The largest segment in the market, bone replacement/grafting, was valued at $714 million in 2007. This also has increased only slightly into 2009 but is projected to reach $979 ...
|
more...
|
$4,850.00
|
|
The 2009-2014 World Outlook for Regenerative Medicine
1/8/2009 | published by: Icon Group International, Inc.
... question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ...
|
more...
|
$795.00
|
|
The 2009 Report on Regenerative Medicine: World Market Segmentation by City
1/5/2009 | published by: Icon Group International, Inc.
... as opposed to regions, continents, or countries. This report covers the top 2000 cities in over 200 countries. It does so by reporting the estimated market size (in terms of latent demand) for each major ...
|
more...
|
$795.00
|
|
The 2009-2014 Outlook for Regenerative Medicine in India
12/2/2008 | published by: Icon Group International, Inc.
... across over 5,000 cities in India. For each city in question, the percent share the city is of it’s state or union territory and of India as a whole is reported. These comparative benchmarks allow ...
|
more...
|
$495.00
|
|
The 2009-2014 Outlook for Regenerative Medicine in Japan
12/2/2008 | published by: Icon Group International, Inc.
... 1,000 cities in Japan. For each city in question, the percent share the city is of it’s prefecture and of Japan is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis ...
|
more...
|
$495.00
|
|
The 2009-2014 Outlook for Regenerative Medicine in Greater China
12/2/2008 | published by: Icon Group International, Inc.
... special administrative regions (Hong Kong and Macau), and Taiwan (all hereafter referred to as “regions”). Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 1,100 cities in ...
|
more...
|
$495.00
|
|
The 2009-2014 Outlook for Regenerative Medicine in the United States
12/2/2008 | published by: Icon Group International, Inc.
... across some 12,900 cities in the United States. For each city in question, the percent share the city is of it’s state and of the United States is reported. These comparative benchmarks allow the reader ...
|
more...
|
$495.00
|
|
Stem Cells in Regenerative Medicine 2008
9/1/2008 | published by: Select Biosciences Limited
... space. Select Biosciences industry coverage in this report focuses on the technical aspects of stem cells—focusing on pluripotency, markers to characterize various stem cells, tables of usage of different types of stem cells and stem ...
|
more...
|
$4,860.00
|
|
Stem Cell Therapies and Regenerative Medicine: Current Applications and Future Possibilities
12/1/2005 | published by: BCC Research
... of funding. However, new companies have sprung up, as new research prompts new avenues of exploration. The political climate for embryonic stem cells has changed. The Bush Administration maintains a ban in the U.S. on ...
|
more...
|
$4,543.00
|
|
Regenerative Medicine: Bone and Joint Applications
7/1/2003 | published by: BCC Research
... as genes and proteins (antibodies, growth factors, hormones); cells and tissues; embryonic stem cells, and biomaterials. At present, most regenerative medicines on the market fall into the first category and include protein-based drugs and therapies ...
|
more...
|
$4,428.00
|
